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To talk about the next challenges and 
the safe utilisation of Bt based prod-
ucts, it is to my thinking extremely 
importantto lookatwhat hasbeen done 
in the past and use " the good, the bad 
and the ugly " that happened, to im-
prove the future. 
In the early 1960% the concept of 
biological control of insect pests was 
not fairly only new, but it involved 
" unusual researchers " claiming that it 
was possible to fight nature with na-
ture. At that time, there were many 
concerns being thrown at the scientific 
community and the public about the 
safety hazards, problems, long term 
effects created by the extensive use of 
chemical pesticides. Still many pesti-
cides were still considered as magie 
bullets, because everytime something 
would be published on the " bad Chem-
icals " another one ( better ! ) would be 
created and rapidly put on the market. 
But thanks to the " persistence " of 
some researchers, the idea of using 
microbes to fight effectively certain 
insect pests that were creating lots of 
damages to forestry and agricultural 
industries, the name Bacillus thuring-
iensis { Bt) becamealmostatrademark. 
Not only to other researchers but also 
to funding agencies !! 
Although known to many people 
working in laboratories, the potential 
of Bt as a microbial insecticide really 
started to develop when expérimental 
field trials were made and showed 
promising results. Using better strains, 
with better efficacies,formulated mate-
rial, improved techniques of applica-
t ion, ail thèse were possible. Some 
people were again dreaming about 
another " magie bullet " even if cau-
tions were thrown ail over the place. 
In the 1970's, formulations were get-
ting registered by regulatory agencies, 
thus providing researchers with the 
possibility of doing large scale experi-
ments. At the same time, basic research 
was being made on the mode of action 
of Bt, strain specificity, dosage of the 
toxic inclusions, discovery of new 
strains, establishment of standards and 
protocols to assay newly discovered 
material. During that period, Bt was 
presented as an idéal microbial agent 
since it did not hâve the drawbacks of 
the " bad chemicals ":. Contrary to the 
Chemicals it had a narrow spectrum of 
activity, a short persistence , thus no 
accumulation in the environment and 
could be produced cheaply using stan-
dard fermentation procédures. 
Up to the 1980's, successes were 
numerous according to the published 
literature. But there were also many 
failures on the field, most of which were 
never published for many reasons. 
Then, there were some doubts as to the 
real effective potential of Bt. Neverthe-
less, progress was being made in many 
areas. Improved formulations or at least 
a whole lot of différent formulations, 
improved delivery techniques, other 
strains with new specificity were dis-
covered. Bacillus thuringiensis israelen-
sis was foundtobe highly active against 
mosquitoes. Malaria, onchocerciasis, 
yellow fever, dengue hémorragie fever 
etc. would eventually become diseases 
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of the past !!! The " magie bullets " 
were increasingly numerous and there 
seemed no limits. 
Later during that period, laboratories 
researchers learned a lot about Bt and 
its toxic constituents, their mode of 
action, species sensitivity etc.. But 
some failures and the fact that the 
market for Bt based products was still 
waiting to reach the expected exponen-
tialgrowth that was claimedat that time, 
produced a strange shift in the mind of 
many people involved in the field of 
biological control using Bt based prod-
ucts. What were advantages compared 
to the " bad chemicals " suddenly be-
came disadvantages. Now the spec-
trum of activity of Bt was too narrow, 
it persistence in the field was to short, 
the timing of the application of the for-
mulation was too difficult, to time con-
suming to users, the costs of the formu-
lation were too high, shelf-life wastoo 
short. 
But it is amazingly interesting to note 
that during the same period, although 
Bt was having a relatively good success 
( potentially speaking ) with the scien-
tific community, the regulatory agen-
cies and the industrial producers, many 
concerns were also raised. 
The scientific community was becom-
ing inquisitive about many things: what 
is really Bt, a pathogen or not ? what 
are the impacts on other populations ? 
can large scale applications to destroy 
a pest affect other species especially 
bénéficiai species ? hâve people made 
long term ecological impact studies ? 
what is présent informulations that 
could cause « colateral « damage? 
After having realised the effects of 
" chemicals pesticides " on the envi-
ronment, well publicised I might add, 
now it was the turn of the public to ask 
questions. The syndrome of "not in my 
back yard" was not a fad but something 
real and it extended to more then the 
backyards. 
Regulatory agencies were also get-
ting some questions, although I must 
admit that because of confidentiality 
agreement involved in homologation 
processes, they were in a rather diffi-
cult position. But still their lack of an-
swers to some questions, promoted 
more awareness and more questions, 
on the part of ecological groups. In turn 
it created another phenomena; thèse 
groups gathered in their ranks, biochem-
ists, microbiologists, mathematical 
modeling experts, economists, and to 
top it ail, lawyers !!! And the média 
were having a good time with this !!! 
Many questions were asked, and some 
people realised that there were no an-
swers because in parts, the necessary 
research had not been done, or had 
been partially done or had been so badly 
done that now the chicken had to go 
back to the barn !!! 
Early 1980's, was the time to step in 
with the " Age of Aquarius ": molecular 
biology. Combined with the biochem-
ical researches done earlier, it was the 
occasion to improve things so that users 
would be happy. They ( !! ) demanded 
larger spectrum of activity, longer per-
sistence, ease of utilisation, low cost of 
application etc. Molecular biology com-
bined with integrated pest management: 
an assortment of magie bullets with a 
better riffle !!! 
During that period, Bt gènes were 
shuffled ail over the place, a tremen-
dous amount of money, time and also 
acquisition of important data were 
made. The gènes went from one spe-
cies to other Bt species, to other bacte-
ria, to plants, to viruses, to " you name 
it we can do it ". Great achievements 
were done with Bt and molecular biol-
ogy. New ( !! ) organisms were devel-
oped so that indeed larger and multi-
spectrum of activity were achieved, but 
the short persistence remained a con-
stant problem. Now there were Bt 
strains with activity against lepidopter-
an, diptera and coleoptera either singly 
or in combinations, giving rise to new 
markets, fresh research money and 
possibly new developments. But always 
there were limitations with the toxicity 
and also the delivery Systems. But when 
we look at the literature, one of the 
many concerns of the molecular biolo-
gists involved in Bt research, was the 
lack of knowledge on the target spe-
cies!! ! Equally important, many new 
serotypes of Bt with différent specifîcity 
and efficacy were discovered and today 
there is at least 51 of them. 
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We can produce good bullets, but we 
do not know enough about the target 
and its highly sophisticated techniques 
of camouflage and we know little on 
how it interacts with its habitat !!! But 
also at the same time, many people 
realised that the enemies ( insects 
pests ) were formidable ones. New for-
mulations, improved delivery Systems 
were developed and tested with some 
success as some informations were 
found on behavior and the life cycle of 
the targets. 
During that period, there were a lot of 
pressure put on regulatory agencies. 
From regulating on the use and the 
environmental effects of chemical pes-
ticides to the émergence of biological 
control using wild-type organisms with 
various formulations, then the appear-
ance of new ( !! ) organisms created by 
molecular biologists, formulated by 
industries, combined with the persis-
tent market pressure and lobbying from 
the promoters and the users. 
The agencies were during that peri-
od, and my feeling is that, they are still 
not prepared to deal adequately, with 
such rapid activity. I think that even 
today they are lacking the necessary 
personnel in number and in qualifica-
tion to investigate and evaluate new 
and improved formulations. What do 
we do ? do we stop everything until we 
get our breath back ? you may hâve to 
recommend to increase the efficacy 
( personal, compétence ) of regulatory 
agencies, but will government accept 
that ? are industries willing to help ? 
The type of pressures put on regula-
tory agencies can be understood, when 
we look at some published literature. I 
would like to résume a paragraph writ-
ten ten years ago, by researchers rep-
resenting an industry involved in bio-
logical control. It is said that : to avoid 
regulatory restrictions associated with 
the testing and use of organisms pro-
duced using recombinant DNAtechnol-
ogy, some people hâve utilised an in-
termediate strategy ( conjugation ). 
Because thèse organisms ( produced 
by conjugation ) are considered by reg-
ulatory agencies to be genetically ma-
nipulated rather than genetically engi-
neered, some were approved for use. 
Does that mean that whenever a set 
of régulations is proposed by the agen-
cies, researchers should try to find a 
way around it ? 
In Canada, the period from 1980 to 
1990 saw many groups of people ob-
jecting to large scale treatment against 
the use of Bt for the control of spruce 
bud worm and other insect pests of 
agricultural importance; and also Bt 
israelensis treatment of marshes and 
rivers against mosquitoes and blackflies 
At the beginning, thèse groups of con-
cerned citizens were composed of envi-
ronmentalists and ordinary people who 
were simply afraid of getting sprayed 
with a bacteria ( and it did happened ! ! ), 
closely related to a known pathogen 
( Bacillus cereus ) and also afraid of what 
would happen to their ecosystem. Some 
researchers worried about the rapid 
progression of expérimental field test-
ings and I guess remembering what 
happened with chemical pesticides, 
started asking questions about the pos-
sibility of résistance of the targets and 
ecological impacts. But the prospect of 
résistance was not highly considered at 
the time because it involved the devel-
opment of résistance to 3-4 toxic mol-
écules acting together on the target. 
Thèse groups were usually confront-
ed against experts representing the 
industries and also people from gov-
ernment agencies sometimes involved 
in research with the producers and the 
promoters ! ! ! It is not surprising today, 
to see independent researchers involved 
with thèse groups and even some are 
well implicated in the field of biological 
control if not directly involved with Bt 
research . 
It is interesting to note that thèse 
groups were actually using the same 
questions raised by researchers admit-
ting ( in books and review of literature ) 
that although a lot of things were 
known about Bt, there was little infor-
mation on the target species and its 
ecology, on the possible long term ef-
fects on the ecosystem, possible effects 
on bénéficiai organisms, persistence in 
various environments, the safety of the 
bacteria and even the safety of other 
constituents of the formulations used. 
Just imagine the concerns raised when 
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promoters started talking about genet-
ically modified or genetically manipu-
lated organisms. 
One important discovery ( in 1987-
89 ) was the acétate technique devel-
oped to detect Bt organisms in many 
types of habitat and the fact that in-
deed Bt strains were found to be dis-
tributed ail over the world. Now sud-
denly Bt was not a freak of nature but 
a species distributed ail over and that 
the species had enormous proprieties 
as far as specificity was concerned, but 
also the fact that this technique provid-
ed a mean and an incentive to find other 
Bt species with différent specificities and 
efficacies. 
In 1991, the first international confér-
ence on Bt was organised in Oxford 
( England ) and grouped researchers 
from microbial ecology, molecular biol-
ogy to protein crystallographers com-
ing from universities, government re-
search agencies to industries. Some 
extremely important progress were 
présentée! and discussed as well as 
future challenges for the many people 
involved in biological control using Bt. 
The expectations for the next décade 
were very high especially for the indus-
tries. But it was the contrary for those 
involved with regulatory agencies who 
thought that research was moving fast-
er that they could make régulations ! ! ! 
During this meeting some important 
statements were made while some 
issues were not or barely addressed by 
invited researchers. Maybe we could 
use that as a basetodiscuss about future 
challenges. 
One invited speaker said and I quote: 
" Thus the stage appears to be set for 
the réalisation of Bt's true potential as 
a bioinsecticide and for substantial 
market expansion. However, current 
technological advances are outstripping 
the ecological knowledge that is re-
quired for their deployment as environ-
mentally acceptable insect control strat-
égies. Ecological risks need to be 
assessed, new regulatory requirements 
hâve to be met, and public acceptance 
has to be gained before transgenic 
plants and living recombinant organ-
isms can be put to use ". 
In actual fact, during this important 
meeting, there was little ornothing on 
" the ecological knowledge ", on " reg-
ulatory needs " and on " the public 
acceptance ". When ecology and risk 
assessment was debated, it was admit-
ted that there had been few published 
quantitative studies on the environmen-
tal impacts of Bt insecticides, but in the 
same paper, it is reported that no ad-
verse environmental impact has been 
reported (publ ished)! ! ! not tosaythe 
least of the fact that wild strains of Bt 
had never been " conclusively " impli-
cated in any human or mammalian 
health incidents. 
How many long term studies on eco-
logical impacts using independent re-
searchers, were funded by industries or 
government agencies ? Who is willing 
to start and fund a five year research 
program involving independent ecolo-
gists, microbiologists, physiologists, 
biochemists etc. 
How can you gain public acceptance 
when one reads that " Bt does not 
persist or spread in the land environ-
ment and that recombinant gènes ex-
pressed in Bt strains will remain within 
or close to the area of release ". How 
do we explain their présence and distri-
bution in nature ? Especially when the 
author makes in the same paper a most 
likely hypothesis, " that soil acts as a 
réservoir or sink for Bt spores which 
may then spread long distances by wind 
dissémination ". 
I would like to end this long but nec-
essary introduction by looking at one of 
the concluding remark made during this 
Oxford meeting: " We now hâve the 
opportunity to demonstrate the lessons 
of past use of chemical insecticides by 
developing sound stratégies for using 
Bt based biotechnology products in pest 
management Systems in advance of 
their actual commercialisation and 
marketing ". In 1980, basically the same 
remark was made except for the " bio-
technology products " part !!!! 
Hâve we really learned lessons from 
the past or are we in the process of 
repeating the same mistakes ? Although 
the problems of résistance are increas-
ing, hâve we developed sound strate-
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gies for pest management to avoid this 
problem ? Hâve we since that meeting 
in Oxford, met the challenges that were 
put forward to the scientific communi-
ty ? Hâve we fill up the scientific gaps 
that were required to meet the concerns 
of many of the participants ? Are we 
going too fast, taking too many risks ? 
is the use of DNA technology the only 
way to improve biological control ? 
It is almost impossible during this 
meeting to discuss of ail the next re-
search challenges especially when I see 
the term " new organisms ". Further-
more, to me research does not only 
means laboratory or field work. Re-
search also involves new ideas, new 
involvements, new agreements, new 
partnerships etc. 
Ail sorts of challenges can be made 
to the various groups attending this 
current meeting. Taken as a whole one 
of the biggest challenge would be as 
was said repeatedly over the last 10-20 
years: to get people from various field 
of research to actually worktogether. In 
fact very seldom do you see in the 
published literature, the necessary as-
sortment of researchers needed to tack-
le some of the questions and concerns 
raised earlier. How many times hâve 
we seen industries, regulating agencies, 
funding agencies and university re-
searchers get together, work together 
and publish together. 
For regulatory agencies, a big and 
most crucial challenge would be to stay 
ahead of the rapid progress in the field 
of biotechnology and research in bio-
logical control so that régulations for 
homologation, expérimental field test-
ing would be sound and adapted to the 
actual reality of the time and costs in-
volved in biological control research. 
Furthermore, somebody, somehow will 
hâve to find ways to increase the num-
ber compétent personal in regulatory 
agencies, so that they can at least fol-
low research progresses and activities. 
In many respect, most agencies are 
behind ail that creating major difficul-
tés for researchers, industries and us-
ers. 
One of the challenge of the regulato-
ry agencies should be to convince fund-
ing agencies to put high priority on 
projects designed to investigate eco-
logical impacts, persistence, résistance 
détection and management stratégies 
etc. implicating multidisciplinary ap-
proaches. 
Another challenge of thèse agencies 
should be to propose to researchers, 
complète, scientifically acceptable and 
standardised protocols for testing new 
strains, newformulations, newdelivery 
technologies for environmental im-
pacts. 
There are many challenges facing 
industries involved in biological control 
using Bt whether as wild strains or as 
modified organisms. Very few if none 
of the industries can carry alone ail the 
research needed to answer the multi-
tude of questions raised by other re-
searchers, by the regulatory agencies 
and by the public. 
Industries will need to do more re-
search using independent university 
researchers. Especially in areas sensi-
tive to the public. They are aware of 
research between industries and gov-
ernment agencies and since it does 
involve confidentiality agreements, it 
is difficult to stay neutral when debat-
ing the pro and cons of biological con-
trol. 
Industries will hâve to do research or 
get the research done, for better under-
standing of the targets . When a pre-
sumed target is not responding, is it 
because of the target itself or the strain 
or the delivery System. Since according 
to many authors many basic knowledge 
of the targets are not investigated suf-
ficiently it may be that failures are not 
the fault of the strain but could be on 
the delivery System. 
Industries will need to investigate 
means of reaching the public and the 
users. Informations on the products, the 
formulations, on the purpose of field 
experiments should be better explained. 
How many times hâve we seen misin-
terpretations, miscalculations and ab-
sences of information on the publicity 
distributed during scientific meeting 
attended by groups opposing biologi-
cal treatments, especially those involv-
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ing genetically modified or manipulat-
ed microorganisms. 
There is an urgent need for research 
on résistance, its occurence, its mecan-
ism and how to manage or avoid it. 
Does résistance occurs during expéri-
mental field trials ? If so, research should 
provide ways to monitor résistance and 
detect it at a very early stage. If users 
are responsible, extensive investiga-
tions should be made to see what went 
wrong. Was it a wrong dosage by the 
user or was it the dosage proposed by 
the industry. 
Finally, are wild type and transformed 
strains of Bt safe to utilise ? Safe for 
environment ? I guess this would be 
quite debatable. As proponents would 
argue: nothing of importance has been 
published. As opponents would answer: 
hâve you looked for it and if you find 
something will you publish it ? 
There has been a fair amount of re-
search done on the innocuity of some 
serotypes of Bt, and the results are good. 
Indeed, there is no conclusive évidence 
implicating Bt and human casualty. 
But some of the research or surveil-
lance program conducted during large 
scale treatments were so badly con-
structed and executed, that in fact " no 
conclusive évidence " could hâve impli-
cated Bt. It is important to know that 
using standard médical microbiology 
laboratory techniques, Bacillus thuring-
iensisw\\\ show up as Bacillus cereusa 
small pathogen rarely implicated in food 
poisoning and in mild intestinal prob-
lems. 
To put forward three questions as a 
base for discussion is a difficult task, 
but hère we go: 
- Are we moving too fast, should we 
slow down and really look at the fail-
ures and the gaps before going to 
molecular biology. 
- How do we explain the fact that al-
though great expectations were put 
forward over the last 15 years, the 
use of Bt based products is still very 
restricted. 
- What can be done in order for indus-
tries, regulating agencies, funding 
agencies, governmentresearch cen-
tersand universitiesto worktogether 
toward the same goal and with the 
same satisfaction. 
49 
